Literature DB >> 29230571

Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.

Hideaki Yuki1, Daisuke Utsunomiya2, Shinya Shiraishi1, Seiji Takashio3, Fumi Sakamoto1, Noriko Tsuda1, Seitaro Oda1, Masafumi Kidoh1, Takeshi Nakaura1, Kenichi Tsujita3, Yasuyuki Yamashita1.   

Abstract

Myocardial perfusion-single-photon emission computed tomography (MP-SPECT) is used to evaluate microvascular dysfunction and coexisting coronary artery disease in patients with hypertrophic cardiomyopathy (HCM). Phase analysis in gated MP-SPECT can provide additional information on left ventricular (LV) dyssynchrony, while the extent of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging is an important prognostic factor in patients with HCM. We, therefore, sought to investigate the relationship of dyssynchrony by phase analysis on gated MP-SPECT and LGE on CMR imaging in 22 patients with HCM who underwent both stress/rest-gated MP-SPECT and contrast-enhanced CMR imaging. LV dyssynchrony parameters [phase standard deviation (SD) and histogram bandwidth] from gated MP-SPECT were compared with LGE parameters from CMR imaging [L/C contrast and %LGE calculated, respectively, as LGE intensity/LV cavity intensity and (LGE volume/myocardial volume) × 100]. Phase SD and histogram bandwidth showed strong correlation with %LGE (r = 0.73, p < 0.0001 and r = 0.73, p < 0.0001, respectively), although they did not significantly correlate with L/C contrast (r = 0.30, p = 0.17 and r = 0.26, p < 0.25, respectively). The LV dyssynchrony derived from gated MP-SPECT strongly correlated with the extent of LGE on CMR imaging. In conclusion, our investigation suggests that gated MP-SPECT may be useful not only for the assessment of myocardial ischemia but also the extent of myocardial replacement fibrosis.

Entities:  

Keywords:  Dyssynchrony; Hypertrophic cardiomyopathy; Magnetic resonance imaging; Phase analysis; Single-photon emission computed tomography

Mesh:

Substances:

Year:  2017        PMID: 29230571     DOI: 10.1007/s00380-017-1104-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 2.  Nuclear imaging in cardiac resynchronization therapy.

Authors:  Maureen M Henneman; Ernst E van der Wall; Claudia Ypenburg; Gabe B Bleeker; Nico R van de Veire; Nina Ajmone Marsan; Ji Chen; Ernest V Garcia; Jos J M Westenberg; Martin J Schalij; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-12       Impact factor: 10.057

3.  Ca2+ current and Ca2+ transients under action potential clamp in guinea pig ventricular myocytes.

Authors:  J Arreola; R T Dirksen; R C Shieh; D J Williford; S S Sheu
Journal:  Am J Physiol       Date:  1991-08

Review 4.  SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony.

Authors:  Ji Chen; Ernest V Garcia; Jeroen J Bax; Ami E Iskandrian; Salvador Borges-Neto; Prem Soman
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

5.  Clinical usefulness of a novel program "Heart Function View" for evaluating cardiac function from gated myocardial perfusion SPECT.

Authors:  Ichiro Nakae; Hideki Hayashi; Tetsuya Matsumoto; Kenichi Mitsunami; Minoru Horie
Journal:  Ann Nucl Med       Date:  2014-07-15       Impact factor: 2.668

Review 6.  Integrated Imaging in Hypertrophic Cardiomyopathy.

Authors:  Lubna Choudhury; Vera H Rigolin; Robert O Bonow
Journal:  Am J Cardiol       Date:  2016-10-11       Impact factor: 2.778

7.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

8.  Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction.

Authors:  Mark A Trimble; Salvador Borges-Neto; Emily F Honeycutt; Linda K Shaw; Robert Pagnanelli; Ji Chen; Ami E Iskandrian; Ernest V Garcia; Eric J Velazquez
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

9.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

Review 10.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.